Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

[Pseudoaneurysm in the subclavian artery as a long-term complication to clavicula fracture].

Ghulam QM, Siddiqi A, Astrup AS.

Ugeskr Laeger. 2014 Dec 1;176(49). pii: V07140401. Danish.

PMID:
25497860
2.

Cardiovascular morbidity and mortality in diabetes mellitus: prediction and prognosis.

Astrup AS.

Dan Med Bull. 2011 Aug;58(8):B4152. Review. No abstract available.

PMID:
21827725
3.

Endothelial progenitor cells in long-standing asymptomatic type 1 diabetic patients with or without diabetic nephropathy.

Reinhard H, Jacobsen PK, Lajer M, Tarnow L, Astrup AS, Kim WY, Pedersen N, Billestrup N, Mandrup-Poulsen T, Parving HH, Rossing P.

Nephron Clin Pract. 2011;118(3):c309-14. doi: 10.1159/000322667. Epub 2011 Jan 21.

PMID:
21252582
4.

Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril.

Nielsen SE, Schjoedt KJ, Astrup AS, Tarnow L, Lajer M, Hansen PR, Parving HH, Rossing P.

Diabet Med. 2010 Oct;27(10):1144-50. doi: 10.1111/j.1464-5491.2010.03083.x.

PMID:
20854382
5.

Telomere length predicts all-cause mortality in patients with type 1 diabetes.

Astrup AS, Tarnow L, Jorsal A, Lajer M, Nzietchueng R, Benetos A, Rossing P, Parving HH.

Diabetologia. 2010 Jan;53(1):45-8. doi: 10.1007/s00125-009-1542-1. Epub 2009 Oct 4.

PMID:
19802713
6.

Effect of adjunct metformin treatment on levels of plasma lipids in patients with type 1 diabetes.

Lund SS, Tarnow L, Astrup AS, Hovind P, Jacobsen PK, Alibegovic AC, Parving I, Pietraszek L, Frandsen M, Rossing P, Parving HH, Vaag AA.

Diabetes Obes Metab. 2009 Oct;11(10):966-77. doi: 10.1111/j.1463-1326.2009.01079.x. Epub 2009 Jun 25.

PMID:
19558610
7.

Tubular and glomerular injury in diabetes and the impact of ACE inhibition.

Nielsen SE, Sugaya T, Tarnow L, Lajer M, Schjoedt KJ, Astrup AS, Baba T, Parving HH, Rossing P.

Diabetes Care. 2009 Sep;32(9):1684-8. doi: 10.2337/dc09-0429. Epub 2009 Jun 5.

8.

Optimal dose of lisinopril for renoprotection in type 1 diabetic patients with diabetic nephropathy: a randomised crossover trial.

Schjoedt KJ, Astrup AS, Persson F, Frandsen E, Boomsma F, Rossing K, Tarnow L, Rossing P, Parving HH.

Diabetologia. 2009 Jan;52(1):46-9. doi: 10.1007/s00125-008-1184-8. Epub 2008 Oct 31.

PMID:
18974967
9.

Effect of adjunct metformin treatment in patients with type-1 diabetes and persistent inadequate glycaemic control. A randomized study.

Lund SS, Tarnow L, Astrup AS, Hovind P, Jacobsen PK, Alibegovic AC, Parving I, Pietraszek L, Frandsen M, Rossing P, Parving HH, Vaag AA.

PLoS One. 2008;3(10):e3363. doi: 10.1371/journal.pone.0003363. Epub 2008 Oct 9.

10.

Markers of endothelial dysfunction and inflammation in type 1 diabetic patients with or without diabetic nephropathy followed for 10 years: association with mortality and decline of glomerular filtration rate.

Astrup AS, Tarnow L, Pietraszek L, Schalkwijk CG, Stehouwer CD, Parving HH, Rossing P.

Diabetes Care. 2008 Jun;31(6):1170-6. doi: 10.2337/dc07-1960. Epub 2008 Mar 10.

PMID:
18332153
11.

Relation of left ventricular function, mass, and volume to NT-proBNP in type 1 diabetic patients.

Astrup AS, Kim WY, Tarnow L, Botnar RM, Simonsen C, Brix L, Pietraszek L, Hansen PR, Manning WJ, Parving HH.

Diabetes Care. 2008 May;31(5):968-70. doi: 10.2337/dc07-1536. Epub 2008 Feb 5.

PMID:
18252905
12.

Plasma alpha-defensin is associated with cardiovascular morbidity and mortality in type 1 diabetic patients.

Joseph G, Tarnow L, Astrup AS, Hansen TK, Parving HH, Flyvbjerg A, Frystyk J.

J Clin Endocrinol Metab. 2008 Apr;93(4):1470-5. doi: 10.1210/jc.2007-1910. Epub 2008 Jan 22.

PMID:
18211979
13.

Predictors of mortality in patients with type 2 diabetes with or without diabetic nephropathy: a follow-up study.

Astrup AS, Nielsen FS, Rossing P, Ali S, Kastrup J, Smidt UM, Parving HH.

J Hypertens. 2007 Dec;25(12):2479-85.

PMID:
17984670
14.

Pregnancy-associated plasma protein A in a large cohort of Type 1 diabetic patients with and without diabetic nephropathy-a prospective follow--up study.

Astrup AS, Tarnow L, Christiansen M, Hansen PR, Parving HH, Rossing P.

Diabet Med. 2007 Dec;24(12):1381-5. Epub 2007 Oct 29.

PMID:
17971180
15.

Subclinical coronary and aortic atherosclerosis detected by magnetic resonance imaging in type 1 diabetes with and without diabetic nephropathy.

Kim WY, Astrup AS, Stuber M, Tarnow L, Falk E, Botnar RM, Simonsen C, Pietraszek L, Hansen PR, Manning WJ, Andersen NT, Parving HH.

Circulation. 2007 Jan 16;115(2):228-35. Epub 2006 Dec 26.

PMID:
17190865
16.

Cardiac autonomic neuropathy predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy.

Astrup AS, Tarnow L, Rossing P, Hansen BV, Hilsted J, Parving HH.

Diabetes Care. 2006 Feb;29(2):334-9.

PMID:
16443883
17.
18.

Improved prognosis in type 1 diabetic patients with nephropathy: a prospective follow-up study.

Astrup AS, Tarnow L, Rossing P, Pietraszek L, Riis Hansen P, Parving HH.

Kidney Int. 2005 Sep;68(3):1250-7.

19.

Monitoring kidney function in diabetic nephropathy.

Rossing P, Astrup AS, Smidt UM, Parving HH.

Diabetologia. 1994 Jul;37(7):708-12.

PMID:
7958543

Supplemental Content

Loading ...
Support Center